	Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI study. NPJ Precis Oncol Rebuzzi SE, Miskovic V, Fornarini G, Ferri S, Buti S, Piceni M, Signori A, Provenzano L, Banna GL, Rescigno P, Maruzzo M, Bimbatti D, Pollone BR, Basso U, De Giorgi U, Pedrazzoli P, Galli L, Zucali PA, Di Costanzo F, Ghose A, Pedrocchi ALG, Prelaj A. PMID: 42393181 [PubMed - as supplied by publisher]
	Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis. Eur Urol Focus Larose C, Samhani C, Piché ME, Lachance G, Fradet Y, Robitaille K, Fradet V. PMID: 42392953 [PubMed - as supplied by publisher]
	Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined (18)F-Flotufolastat PSMA PET and mpMRI. J Nucl Med Hekimsoy T, Sauter AP, Tauber R, Horn T, Jahnen M, Horné F, Petzold JQ, Sasse D, Rauscher I, Eiber M, Weber WA, Erber BM. PMID: 42392697 [PubMed - as supplied by publisher]
	Re: Twelve-month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-sparing Therapy for Recurrent High-grade Non-muscle-invasive Bladder Cancer: Recurrent High-risk NMIBC: One Bladder, Choose Wisely. Eur Urol Contieri R, van der Heijden AG, Mertens LS. PMID: 42392908 [PubMed - as supplied by publisher]
	Sensitive detection of prostate cancer antigen 3 (PCA3) in urine based upon CRISPR/Cas12a and gold nanorods (AuNRs). Spectrochim Acta A Mol Biomol Spectrosc Liao W, Li S, Wu S, Yang X, Liu B, Ling L, Zeng Q, Zhang J. PMID: 42391902 [PubMed - as supplied by publisher]
	Assessing the impact of prostate cancer prevention and detection initiatives. Int J Palliat Nurs Narvaez RA, Bongay R, Federez IC, Chan EB, Magno D, Samarita JC, Ferrer M, Peco RA, Sumpay LA, Sangilan NB. PMID: 42391137 [PubMed - indexed for MEDLINE]
	Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer. Clin Cancer Res Lotan Y, Luu M, Liu M, Tikhonekov S, Kobayashi T, Ahdoot M, Kim HL, Porten S, Peers G, Kita Y, Daskivich T, Murakami K, Sakatani T, Pagano I, Zheng Y, Zhang Z, Furuya H, Rosser CJ. PMID: 42391037 [PubMed - as supplied by publisher]
	Comprehensive Approach to Prostate Cancer Metastasis Mimics at Prostate-Specific Membrane Antigen PET/CT. Radiographics Rafiei Alavi N, Gupta A, Rahmani M, Alexander S, Afsari A, Jafarvand Giglou M, Srinivas SM, Yaghmai V. PMID: 42391030 [PubMed - indexed for MEDLINE]
	Safety and efficacy of different surgical approaches in single-port robot-assisted radical prostatectomy based on propensity score matching analysis. World J Urol Qi JC, Liu L, Tang S, Yang HX, Santodirocco L, Xia YR, Morgantini LA, Sauer Calvo R, Qu CB, Wang YX, Crivellaro S. PMID: 42390762 [PubMed - indexed for MEDLINE]
	HER2 assessment in urothelial carcinoma: standardization challenges and the path forward. Cancer Metastasis Rev Xie P, Wang Y, Lu L, Chen J, Wei J, Huang Y, Guo C, Li J, Yan X, Guo J, Wu X, Sheng X. PMID: 42390654 [PubMed - indexed for MEDLINE]
	Transurethral Ropivacaine (100 mg) Bladder Irrigation Reduces the Incidence of Bladder Discomfort in Transurethral Resection of Bladder Tumor: A Randomized Double-blind Trial. Ann Afr Med Ranjan R, Singh AK, Sachan S, Singh Y, Gupta R, Nayak AK, Kumar R, Bhargavan A. PMID: 42390337 [PubMed - as supplied by publisher]
	Ablative radiotherapy in castration-resistant prostate cancer. BJU Int Hölscher T, Lohaus F, Koi L, Kotzerke J, Hoberück S, Thomas C, Borkowetz A, Löck S, Krause M, Troost EGC. PMID: 42389925 [PubMed - as supplied by publisher]
	Venous thromboembolism after penile cancer surgery: a UK PeCaN study. BJU Int Kaur A, El-Taji O, Alnajjar H, Ayres B, Christodoulidou M, Eardley I, Elmamoun M, Goddard J, Gordon P, Hadway P, Kalejaiye O, Keegan P, Kumar V, Lau M, Manjunath A, McGuinness L, Mulholland C, Muneer A, Panagiotis C, Randhawa K, Sahdev V, Shukla C, Watkin N, Sachdeva A, Parnham A, Sangar V. PMID: 42389899 [PubMed - as supplied by publisher]
	Microbial dysbiosis and inferred functional profiling reveals the potential role of Methylobacterium in prostate cancer. Front Cell Infect Microbiol Al Shareef ZM, Al-Shahrabi RM, Sharif-Askari FS, Yener B, Bhamidimarri PM, Bouzid A, Talaat IM, Bendardaf R, Hamoudi RA, Mote S, Mall R, Castiglione F. PMID: 42389510 [PubMed - indexed for MEDLINE]
	Unveiling the comorbidity hub: WT1 drives renal cancer progression in chronic kidney disease and confers sirolimus vulnerability. Exp Ther Med Zhang W, Tang P, Wu S, Sui Z. PMID: 42389452 [PubMed]
	Potential Anticancer Effects of Limonene Associated with Reactive Oxygen Species Generation, Apoptosis Induction, and NF-ÎºB Modulation in Papillary Renal Cell Carcinoma: A Preliminary Study. Curr Dev Nutr Ghanbari M, Deyhimfar R, Khatami F, Haghani I, Menbari Oskouie I, Khoshchehreh M, Kazem Aghamir SM. PMID: 42388892 [PubMed]
	Urban residents' health literacy of four major cancers: a cross-sectional national survey. Front Public Health Lyu Y, Guo W, Wang Z, Paterson C, Lin F. PMID: 42388744 [PubMed - indexed for MEDLINE]
	Cuproptosis and prostate cancer: from molecular mechanisms and microenvironment remodeling to precision therapy. Front Oncol Tang Z, Shen S, Guo C, Chen A, Yang D, Sun J, Mi Y. PMID: 42388635 [PubMed]
	Comparative effectiveness and integrated safety of goserelin sustained-release microspheres versus implants in prostate cancer: a patient-based real-world study and systematic review with meta-analysis. Front Oncol Zhao J, Zhao Q, Liu X, Hou K, Chen Y, Lan H, Ping Y. PMID: 42388614 [PubMed]
	An exploratory study of BLCA-4 expression, STR analysis, and urothelial cytology in smokers versus non-smokers with bladder cancer. Front Oncol Momenah MA, Al-Qahtani WS. PMID: 42388612 [PubMed]

Articles 1 - 20 / 179710

Page 1 of 8986



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy